Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company’s platform helps members address musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients. The Company’s clients are self-insured employers.
2016
n/a
LTM Revenue $572M
LTM EBITDA $107M
$2.6B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of December 2025, Hinge Health reported last 12-month revenue of $572M and EBITDA of $107M.
In the same period, Hinge Health generated $468M in LTM gross profit and -$546M in net income.
See Hinge Health valuation multiples based on analyst estimatesIn the most recent fiscal year, Hinge Health reported revenue of $390M and EBITDA of -$26.0M.
Hinge Health expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Hinge Health valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $572M | XXX | $390M | XXX | XXX | XXX |
| Gross Profit | $468M | XXX | $300M | XXX | XXX | XXX |
| Gross Margin | 82% | XXX | 77% | XXX | XXX | XXX |
| EBITDA | $107M | XXX | -$26.0M | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | -7% | XXX | XXX | XXX |
| EBIT | $106M | XXX | -$31.9M | XXX | XXX | XXX |
| EBIT Margin | 18% | XXX | -8% | XXX | XXX | XXX |
| Net Profit | -$546M | XXX | -$11.9M | XXX | XXX | XXX |
| Net Margin | -95% | XXX | -3% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Hinge Health has current market cap of $2.9B, and EV of $2.6B.
As of January 30, 2026, Hinge Health's stock price is $36.
See Hinge Health trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $2.6B | $2.9B | XXX | XXX | XXX | XXX | $1.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialHinge Health's trades at 4.5x EV/Revenue multiple, and 24.1x EV/EBITDA.
See valuation multiples for Hinge Health and 15K+ public compsAs of January 30, 2026, Hinge Health has market cap of $2.9B and EV of $2.6B.
Equity research analysts estimate Hinge Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Hinge Health has a P/E ratio of -5.2x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $2.9B | XXX | $2.9B | XXX | XXX | XXX |
| EV (current) | $2.6B | XXX | $2.6B | XXX | XXX | XXX |
| EV/Revenue | 4.5x | XXX | 4.5x | XXX | XXX | XXX |
| EV/EBITDA | 24.1x | XXX | 24.1x | XXX | XXX | XXX |
| EV/EBIT | 24.4x | XXX | 24.4x | XXX | XXX | XXX |
| EV/Gross Profit | 5.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | -5.2x | XXX | -5.2x | XXX | XXX | XXX |
| EV/FCF | 17.1x | XXX | 17.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialHinge Health's last 12 month revenue growth is 22%
Hinge Health's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.
Hinge Health's rule of 40 is -21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Hinge Health's rule of X is 72% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Hinge Health and other 15K+ public comps| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 22% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| EBITDA Growth | 31% | XXX | n/a | XXX | XXX | XXX |
| Rule of 40 | -21% | XXX | 40% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 72% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | n/a | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 43% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 26% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 85% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| National Healthcare Corp | XXX | XXX | XXX | XXX | XXX | XXX |
| Eureka Group Holdings | XXX | XXX | XXX | XXX | XXX | XXX |
| Propel Funeral Partners | XXX | XXX | XXX | XXX | XXX | XXX |
| Regis Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Maternus-Kliniken | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Hinge Health acquired XXX companies to date.
Last acquisition by Hinge Health was XXXXXXXX, XXXXX XXXXX XXXXXX . Hinge Health acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Hinge Health founded? | Hinge Health was founded in 2016. |
| Where is Hinge Health headquartered? | Hinge Health is headquartered in United States of America. |
| Who is the CEO of Hinge Health? | Hinge Health's CEO is Mr. Daniel Perez. |
| Is Hinge Health publicy listed? | Yes, Hinge Health is a public company listed on NYS. |
| What is the stock symbol of Hinge Health? | Hinge Health trades under HNGE ticker. |
| When did Hinge Health go public? | Hinge Health went public in 2025. |
| Who are competitors of Hinge Health? | Similar companies to Hinge Health include e.g. National Healthcare Corp, Eureka Group Holdings, Propel Funeral Partners, Regis Healthcare. |
| What is the current market cap of Hinge Health? | Hinge Health's current market cap is $2.9B |
| What is the current revenue of Hinge Health? | Hinge Health's last 12 months revenue is $572M. |
| What is the current revenue growth of Hinge Health? | Hinge Health revenue growth (NTM/LTM) is 22%. |
| What is the current EV/Revenue multiple of Hinge Health? | Current revenue multiple of Hinge Health is 4.5x. |
| Is Hinge Health profitable? | Yes, Hinge Health is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Hinge Health? | Hinge Health's last 12 months EBITDA is $107M. |
| What is Hinge Health's EBITDA margin? | Hinge Health's last 12 months EBITDA margin is 19%. |
| What is the current EV/EBITDA multiple of Hinge Health? | Current EBITDA multiple of Hinge Health is 24.1x. |
| What is the current FCF of Hinge Health? | Hinge Health's last 12 months FCF is $151M. |
| What is Hinge Health's FCF margin? | Hinge Health's last 12 months FCF margin is 26%. |
| What is the current EV/FCF multiple of Hinge Health? | Current FCF multiple of Hinge Health is 17.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.